{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:23:06Z","timestamp":1783444986625,"version":"3.54.6"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rossy Family Foundation"},{"DOI":"10.13039\/501100003136","name":"Edmond J. Safra Philanthropic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001805","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["40480"],"award-info":[{"award-number":["40480"]}],"id":[{"id":"10.13039\/501100001805","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council of Australia Ideas grant","award":["214090508"],"award-info":[{"award-number":["214090508"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Misfolded \u03b1-synuclein (\u03b1-syn) is believed to contribute to neurodegeneration in Lewy body disease (LBD) based on considerable evidence including a gene-dosage effect observed in relation to point mutations and multiplication of <jats:italic>SNCA<\/jats:italic> in familial Parkinson\u2019s disease. A contradictory concept proposes early loss of the physiological \u03b1-syn as the major driver of neurodegeneration. There is a paucity of data on <jats:italic>SNCA<\/jats:italic> transcripts in various \u03b1-syn immunoreactive cytopathologies. Here, the total cell body, nuclear, and cytoplasmic area density of <jats:italic>SNCA<\/jats:italic> transcripts in neurons without and with various \u03b1-syn immunoreactive cytopathologies in the substantia nigra and amygdala in autopsy cases of LBD (n\u2009=\u20095) were evaluated using RNAscope combined with immunofluorescence for disease-associated \u03b1-syn. Single-nucleus RNA sequencing was performed to elucidate cell-type specific <jats:italic>SNCA<\/jats:italic> expression in non-diseased frontal cortex (n\u2009=\u20093). <jats:italic>SNCA<\/jats:italic> transcripts were observed in the neuronal nucleus and cytoplasm in neurons without \u03b1-syn, those containing punctate \u03b1-syn immunoreactivity, irregular-shaped compact inclusion, and brainstem-type and cortical-type LBs. However, <jats:italic>SNCA<\/jats:italic> transcripts were only rarely found in the \u03b1-syn immunoreactive LB areas. The total cell body <jats:italic>SNCA<\/jats:italic> transcript area densities in neurons with punctate \u03b1-syn immunoreactivity were preserved but were significantly reduced in neurons with compact \u03b1-syn inclusions both in the substantia nigra and amygdala. This reduction was also observed in the cytoplasm but not in the nucleus. Only single <jats:italic>SNCA<\/jats:italic> transcripts were detected in astrocytes with or without disease-associated\u00a0\u03b1-syn immunoreactivity in the amygdala. Single-nucleus RNA sequencing revealed that excitatory and inhibitory neurons, oligodendrocyte progenitor cells, oligodendrocytes, and homeostatic microglia expressed <jats:italic>SNCA<\/jats:italic> transcripts, while expression was largely absent in astrocytes and microglia. The preserved cellular <jats:italic>SNCA<\/jats:italic> expression in the more abundant non-Lewy body type \u03b1-syn cytopathologies might provide a pool for local protein production that can aggregate and serve as a seed for misfolded \u03b1-syn. Successful segregation of disease-associated \u03b1-syn is associated with the exhaustion of <jats:italic>SNCA<\/jats:italic> production in the terminal cytopathology, the Lewy body. Our observations inform therapy development focusing on targeting <jats:italic>SNCA<\/jats:italic> transcription in LBD.<\/jats:p>","DOI":"10.1186\/s40478-023-01687-7","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:03:00Z","timestamp":1700740980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neuronal SNCA transcription during Lewy body formation"],"prefix":"10.1186","volume":"11","author":[{"given":"Tomoya","family":"Kon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Martinez\u2011Valbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasna","family":"Nassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed J.","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"1687_CR1","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","volume":"11","author":"D Agarwal","year":"2020","unstructured":"Agarwal D, Sandor C, Volpato V, Caffrey TM, Monzon-Sandoval J, Bowden R et al (2020) A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat Commun 11:4183. https:\/\/doi.org\/10.1038\/s41467-020-17876-0","journal-title":"Nat Commun"},{"key":"1687_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-022-01468-8","volume":"10","author":"MF Altay","year":"2022","unstructured":"Altay MF, Liu AKL, Holton JL, Parkkinen L, Lashuel HA (2022) Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathol Commun 10:163. https:\/\/doi.org\/10.1186\/s40478-022-01468-8","journal-title":"Acta Neuropathol Commun"},{"key":"1687_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/glia.22653","volume":"62","author":"YT Asi","year":"2014","unstructured":"Asi YT, Simpson JE, Heath PR, Wharton SB, Lees AJ, Revesz T et al (2014) Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia 62:964\u2013970. https:\/\/doi.org\/10.1002\/glia.22653","journal-title":"Glia"},{"key":"1687_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141:159\u2013172. https:\/\/doi.org\/10.1007\/s00401-020-02255-2","journal-title":"Acta Neuropathol"},{"key":"1687_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2990.2004.00572.x","volume":"30","author":"K Beyer","year":"2004","unstructured":"Beyer K, Lao JI, Carrato C, Mate JL, Lopez D, Ferrer I et al (2004) Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies. Neuropathol Appl Neurobiol 30:601\u2013607. https:\/\/doi.org\/10.1111\/j.1365-2990.2004.00572.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1687_CR6","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, Muggeo S, Massimino L, Marzi MJ, Giannelli SG, Melacini E et al (2021) Microglia-specific overexpression of alpha-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun 12:6237. https:\/\/doi.org\/10.1038\/s41467-021-26519-x","journal-title":"Nat Commun"},{"key":"1687_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ejn.13760","volume":"47","author":"G Borrageiro","year":"2018","unstructured":"Borrageiro G, Haylett W, Seedat S, Kuivaniemi H, Bardien S (2018) A review of genome-wide transcriptomics studies in Parkinson\u2019s disease. Eur J Neurosci 47:1\u201316. https:\/\/doi.org\/10.1111\/ejn.13760","journal-title":"Eur J Neurosci"},{"key":"1687_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"1687_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114:231\u2013241. https:\/\/doi.org\/10.1007\/s00401-007-0244-3","journal-title":"Acta Neuropathol"},{"key":"1687_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41576-020-0258-4","volume":"21","author":"C Buccitelli","year":"2020","unstructured":"Buccitelli C, Selbach M (2020) mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet 21:630\u2013644. https:\/\/doi.org\/10.1038\/s41576-020-0258-4","journal-title":"Nat Rev Genet"},{"key":"1687_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nbd.2017.04.011","volume":"103","author":"F Cavaliere","year":"2017","unstructured":"Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M et al (2017) In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiol Dis 103:101\u2013112. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.011","journal-title":"Neurobiol Dis"},{"key":"1687_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/mds.21007","volume":"21","author":"O Chiba-Falek","year":"2006","unstructured":"Chiba-Falek O, Lopez GJ, Nussbaum RL (2006) Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 21:1703\u20131708. https:\/\/doi.org\/10.1002\/mds.21007","journal-title":"Mov Disord"},{"key":"1687_CR13","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1093\/brain\/awz296","volume":"142","author":"Y Chu","year":"2019","unstructured":"Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J et al (2019) Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain 142:3565\u20133579. https:\/\/doi.org\/10.1093\/brain\/awz296","journal-title":"Brain"},{"key":"1687_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.21223","volume":"22","author":"JC Dachsel","year":"2007","unstructured":"Dachsel JC, Lincoln SJ, Gonzalez J, Ross OA, Dickson DW, Farrer MJ (2007) The ups and downs of alpha-synuclein mRNA expression. Mov Disord 22:293\u2013295. https:\/\/doi.org\/10.1002\/mds.21223","journal-title":"Mov Disord"},{"key":"1687_CR15","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L et al (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106:13010\u201313015. https:\/\/doi.org\/10.1073\/pnas.0903691106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1687_CR16","doi-asserted-by":"publisher","first-page":"e0128651","DOI":"10.1371\/journal.pone.0128651","volume":"10","author":"AA Dijkstra","year":"2015","unstructured":"Dijkstra AA, Ingrassia A, de Menezes RX, van Kesteren RE, Rozemuller AJ, Heutink P et al (2015) Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia Nigra in early stage Parkinson\u2019s disease. PLoS ONE 10:e0128651. https:\/\/doi.org\/10.1371\/journal.pone.0128651","journal-title":"PLoS ONE"},{"key":"1687_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul M, Holmqvist S, Boza-Serrano A, Azevedo C, Yeung MS, Goldwurm S et al (2015) Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Reports 5:174\u2013184. https:\/\/doi.org\/10.1016\/j.stemcr.2015.07.002","journal-title":"Stem Cell Reports"},{"key":"1687_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","volume":"24","author":"PE Duffy","year":"1965","unstructured":"Duffy PE, Tennyson VM (1965) Phase and electron micromicroscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson\u2019s disease. J Neuropathol Exp Neurol 24:398\u2013414","journal-title":"J Neuropathol Exp Neurol"},{"key":"1687_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.15252\/msb.20167144","volume":"12","author":"F Edfors","year":"2016","unstructured":"Edfors F, Danielsson F, Hallstrom BM, Kall L, Lundberg E, Ponten F et al (2016) Gene-specific correlation of RNA and protein levels in human cells and tissues. Mol Syst Biol 12:883","journal-title":"Mol Syst Biol"},{"key":"1687_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-017-1787-6","volume":"135","author":"D Erskine","year":"2018","unstructured":"Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J et al (2018) Regional levels of physiological alpha-synuclein are directly associated with Lewy body pathology. Acta Neuropathol 135:153\u2013154. https:\/\/doi.org\/10.1007\/s00401-017-1787-6","journal-title":"Acta Neuropathol"},{"key":"1687_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamaneurol.2022.4193","volume":"80","author":"AJ Espay","year":"2023","unstructured":"Espay AJ, Okun MS (2023) Abandoning the proteinopathy paradigm in Parkinson disease. JAMA Neurol 80:123\u2013124. https:\/\/doi.org\/10.1001\/jamaneurol.2022.4193","journal-title":"JAMA Neurol"},{"key":"1687_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-323-85555-6.00001-1","volume":"193","author":"K Ezzat","year":"2023","unstructured":"Ezzat K, Sturchio A, Espay AJ (2023) The shift to a proteinopenia paradigm in neurodegeneration. Handb Clin Neurol 193:23\u201332. https:\/\/doi.org\/10.1016\/B978-0-323-85555-6.00001-1","journal-title":"Handb Clin Neurol"},{"key":"1687_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M et al (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174\u2013179. https:\/\/doi.org\/10.1002\/ana.10846","journal-title":"Ann Neurol"},{"key":"1687_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060747","author":"IH Flones","year":"2022","unstructured":"Flones IH, Nyland H, Sandnes DA, Alves GW, Tysnes OB, Tzoulis C (2022) Early forms of alpha-synuclein pathology are associated with neuronal complex I deficiency in the substantia Nigra of individuals with Parkinson\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom12060747","journal-title":"Biomolecules"},{"key":"1687_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-023-02604-x","volume":"146","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Lee S, Nassir N, Martinez-Valbuena I, Sackmann V, Li J et al (2023) Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy. Acta Neuropathol 146:395\u2013414. https:\/\/doi.org\/10.1007\/s00401-023-02604-x","journal-title":"Acta Neuropathol"},{"key":"1687_CR26","first-page":"266","volume":"2","author":"H Fujishiro","year":"2013","unstructured":"Fujishiro H, Imamura AY, Lin WL, Uchikado H, Mark MH, Golbe LI et al (2013) Diversity of pathological features other than Lewy bodies in familial Parkinson\u2019s disease due to SNCA mutations. Am J Neurodegener Dis 2:266\u2013275","journal-title":"Am J Neurodegener Dis"},{"key":"1687_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol 9:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"1687_CR28","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gkn084","volume":"36","author":"J Grundemann","year":"2008","unstructured":"Grundemann J, Schlaudraff F, Haeckel O, Liss B (2008) Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson\u2019s disease. Nucleic Acids Res 36:e38. https:\/\/doi.org\/10.1093\/nar\/gkn084","journal-title":"Nucleic Acids Res"},{"key":"1687_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2164-10-365","volume":"10","author":"M Gry","year":"2009","unstructured":"Gry M, Rimini R, Stromberg S, Asplund A, Ponten F, Uhlen M et al (2009) Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 10:365. https:\/\/doi.org\/10.1186\/1471-2164-10-365","journal-title":"BMC Genomics"},{"key":"1687_CR30","doi-asserted-by":"publisher","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM et al (2002) Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem 277:49071\u201349076. https:\/\/doi.org\/10.1074\/jbc.M208046200","journal-title":"J Biol Chem"},{"key":"1687_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","volume":"143","author":"SAM Holec","year":"2022","unstructured":"Holec SAM, Liu SL, Woerman AL (2022) Consequences of variability in alpha-synuclein fibril structure on strain biology. Acta Neuropathol 143:311\u2013330. https:\/\/doi.org\/10.1007\/s00401-022-02403-w","journal-title":"Acta Neuropathol"},{"key":"1687_CR32","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J et al (2023) Cell Marker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res 51:D870\u2013D876. https:\/\/doi.org\/10.1093\/nar\/gkac947","journal-title":"Nucleic Acids Res"},{"key":"1687_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0022-510x(03)00037-6","volume":"211","author":"O Katsuse","year":"2003","unstructured":"Katsuse O, Iseki E, Marui W, Kosaka K (2003) Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 211:29\u201335. https:\/\/doi.org\/10.1016\/s0022-510x(03)00037-6","journal-title":"J Neurol Sci"},{"key":"1687_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/mds.10683","volume":"19","author":"AE Kingsbury","year":"2004","unstructured":"Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ (2004) Alteration in alpha-synuclein mRNA expression in Parkinson\u2019s disease. Mov Disord 19:162\u2013170. https:\/\/doi.org\/10.1002\/mds.10683","journal-title":"Mov Disord"},{"key":"1687_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/neup.12597","volume":"40","author":"T Kon","year":"2020","unstructured":"Kon T, Tomiyama M, Wakabayashi K (2020) Neuropathology of Lewy body disease: clinicopathological crosstalk between typical and atypical cases. Neuropathology 40:30\u201339. https:\/\/doi.org\/10.1111\/neup.12597","journal-title":"Neuropathology"},{"key":"1687_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-022-01403-x","volume":"10","author":"DJ Koss","year":"2022","unstructured":"Koss DJ, Erskine D, Porter A, Palmoski P, Menon H, Todd OGJ et al (2022) Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathol Commun 10:98. https:\/\/doi.org\/10.1186\/s40478-022-01403-x","journal-title":"Acta Neuropathol Commun"},{"key":"1687_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","volume":"69","author":"GG Kovacs","year":"2014","unstructured":"Kovacs GG, Breydo L, Green R, Kis V, Puska G, Lorincz P et al (2014) Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis 69:76\u201392. https:\/\/doi.org\/10.1016\/j.nbd.2014.05.020","journal-title":"Neurobiol Dis"},{"key":"1687_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00401-002-0550-8","volume":"104","author":"GG Kovacs","year":"2002","unstructured":"Kovacs GG, Voigtlander T, Hainfellner JA, Budka H (2002) Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases. Acta Neuropathol 104:320\u2013326. https:\/\/doi.org\/10.1007\/s00401-002-0550-8","journal-title":"Acta Neuropathol"},{"key":"1687_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N et al (2012) An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37\u201350. https:\/\/doi.org\/10.1007\/s00401-012-0964-x","journal-title":"Acta Neuropathol"},{"key":"1687_CR40","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253. https:\/\/doi.org\/10.1093\/jnen\/62.12.1241","journal-title":"J Neuropathol Exp Neurol"},{"key":"1687_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2021.08.001","volume":"90","author":"A Lang","year":"2021","unstructured":"Lang A, Dassler E, Milenkovic I, Lutz MI, Kovacs GG (2021) Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of alpha-synuclein. Parkinsonism Relat Disord 90:57\u201361. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.001","journal-title":"Parkinsonism Relat Disord"},{"key":"1687_CR42","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH et al (2022) Trial of cinpanemab in early Parkinson\u2019s disease. N Engl J Med 387:408\u2013420. https:\/\/doi.org\/10.1056\/NEJMoa2203395","journal-title":"N Engl J Med"},{"key":"1687_CR43","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S et al (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272. https:\/\/doi.org\/10.1074\/jbc.M109.081125","journal-title":"J Biol Chem"},{"key":"1687_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","volume":"82","author":"V Lindstrom","year":"2017","unstructured":"Lindstrom V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A et al (2017) Extensive uptake of alpha-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci 82:143\u2013156. https:\/\/doi.org\/10.1016\/j.mcn.2017.04.009","journal-title":"Mol Cell Neurosci"},{"key":"1687_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","volume":"134","author":"F Loria","year":"2017","unstructured":"Loria F, Vargas JY, Bousset L, Syan S, Salles A, Melki R et al (2017) alpha-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol 134:789\u2013808. https:\/\/doi.org\/10.1007\/s00401-017-1746-2","journal-title":"Acta Neuropathol"},{"key":"1687_CR46","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR et al (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106:20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1687_CR47","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815. https:\/\/doi.org\/10.1523\/JNEUROSCI.08-08-02804.1988","journal-title":"J Neurosci"},{"key":"1687_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-022-02453-0","volume":"144","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena I, Swinkin E, Santamaria E, Fernandez-Irigoyen J, Sackmann V, Kim A et al (2022) alpha-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders. Acta Neuropathol 144:167\u2013185. https:\/\/doi.org\/10.1007\/s00401-022-02453-0","journal-title":"Acta Neuropathol"},{"key":"1687_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","volume":"11","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena I, Visanji NP, Kim A, Lau HHC, So RWL, Alshimemeri S et al (2022) Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy. Transl Neurodegener 11:7. https:\/\/doi.org\/10.1186\/s40035-022-00283-4","journal-title":"Transl Neurodegener"},{"key":"1687_CR50","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1212\/01.wnl.0000127517.33208.f4","volume":"62","author":"DW Miller","year":"2004","unstructured":"Miller DW, Hague SM, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson MR et al (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835\u20131838. https:\/\/doi.org\/10.1212\/01.wnl.0000127517.33208.f4","journal-title":"Neurology"},{"key":"1687_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"1687_CR52","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00401-007-0316-4","volume":"115","author":"F Mori","year":"2008","unstructured":"Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K (2008) alpha-Synuclein pathology in the neostriatum in Parkinson\u2019s disease. Acta Neuropathol 115:453\u2013459. https:\/\/doi.org\/10.1007\/s00401-007-0316-4","journal-title":"Acta Neuropathol"},{"key":"1687_CR53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/1531-8257(199905)14:3<417::aid-mds1005>3.0.co;2-x","volume":"14","author":"M Neystat","year":"1999","unstructured":"Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson\u2019s disease. Mov Disord 14:417\u2013422. https:\/\/doi.org\/10.1002\/1531-8257(199905)14:3%3c417::aid-mds1005%3e3.0.co;2-x","journal-title":"Mov Disord"},{"key":"1687_CR54","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","volume":"10","author":"VR Osterberg","year":"2015","unstructured":"Osterberg VR, Spinelli KJ, Weston LJ, Luk KC, Woltjer RL, Unni VK (2015) Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep 10:1252\u20131260. https:\/\/doi.org\/10.1016\/j.celrep.2015.01.060","journal-title":"Cell Rep"},{"key":"1687_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","volume":"387","author":"G Pagano","year":"2022","unstructured":"Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K et al (2022) Trial of prasinezumab in early-stage Parkinson\u2019s disease. N Engl J Med 387:421\u2013432. https:\/\/doi.org\/10.1056\/NEJMoa2202867","journal-title":"N Engl J Med"},{"key":"1687_CR56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/mds.21466","volume":"22","author":"S Papapetropoulos","year":"2007","unstructured":"Papapetropoulos S, Adi N, Mash DC, Shehadeh L, Bishopric N, Shehadeh L (2007) Expression of alpha-synuclein mRNA in Parkinson\u2019s disease. Mov Disord 22:1057\u20131059. https:\/\/doi.org\/10.1002\/mds.21466","journal-title":"Mov Disord"},{"key":"1687_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U","volume":"62","author":"C Richter-Landsberg","year":"2000","unstructured":"Richter-Landsberg C, Gorath M, Trojanowski JQ, Lee VM (2000) alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J Neurosci Res 62:9\u201314. https:\/\/doi.org\/10.1002\/1097-4547(20001001)62:1%3c9::AID-JNR2%3e3.0.CO;2-U","journal-title":"J Neurosci Res"},{"key":"1687_CR58","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","volume":"126","author":"P Riederer","year":"2019","unstructured":"Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C et al (2019) alpha-Synuclein in Parkinson\u2019s disease: Causal or bystander? J Neural Transm 126:815\u2013840. https:\/\/doi.org\/10.1007\/s00702-019-02025-9","journal-title":"J Neural Transm"},{"key":"1687_CR59","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nmeth1026","volume":"4","author":"MJ Roberti","year":"2007","unstructured":"Roberti MJ, Bertoncini CW, Klement R, Jares-Erijman EA, Jovin TM (2007) Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat Methods 4:345\u2013351. https:\/\/doi.org\/10.1038\/nmeth1026","journal-title":"Nat Methods"},{"key":"1687_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/s0006-8993(01)02772-x","volume":"914","author":"E Rockenstein","year":"2001","unstructured":"Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E (2001) Altered expression of the synuclein family mRNA in Lewy body and Alzheimer\u2019s disease. Brain Res 914:48\u201356. https:\/\/doi.org\/10.1016\/s0006-8993(01)02772-x","journal-title":"Brain Res"},{"key":"1687_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orru CD et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"key":"1687_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/path.1710990106","volume":"99","author":"S Roy","year":"1969","unstructured":"Roy S, Wolman L (1969) Ultrastructural observations in Parkinsonism. J Pathol 99:39\u201344. https:\/\/doi.org\/10.1002\/path.1710990106","journal-title":"J Pathol"},{"key":"1687_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","volume":"138","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Giasson BI, Chakrabarty P (2019) alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol 138:1\u201321. https:\/\/doi.org\/10.1007\/s00401-019-01977-2","journal-title":"Acta Neuropathol"},{"key":"1687_CR64","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41583-023-00697-7","volume":"24","author":"N Stefanova","year":"2023","unstructured":"Stefanova N, Wenning GK (2023) Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms. Nat Rev Neurosci 24:334\u2013346. https:\/\/doi.org\/10.1038\/s41583-023-00697-7","journal-title":"Nat Rev Neurosci"},{"key":"1687_CR65","doi-asserted-by":"publisher","first-page":"1034072","DOI":"10.3389\/fphar.2022.1034072","volume":"13","author":"V Suvarna","year":"2022","unstructured":"Suvarna V, Deshmukh K, Murahari M (2022) miRNA and antisense oligonucleotide-based alpha-synuclein targeting as disease-modifying therapeutics in Parkinson\u2019s disease. Front Pharmacol 13:1034072. https:\/\/doi.org\/10.3389\/fphar.2022.1034072","journal-title":"Front Pharmacol"},{"key":"1687_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10048-016-0478-0","volume":"17","author":"L Tagliafierro","year":"2016","unstructured":"Tagliafierro L, Chiba-Falek O (2016) Up-regulation of SNCA gene expression: implications to synucleinopathies. Neurogenetics 17:145\u2013157. https:\/\/doi.org\/10.1007\/s10048-016-0478-0","journal-title":"Neurogenetics"},{"key":"1687_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12565-018-0464-8","volume":"94","author":"K Taguchi","year":"2019","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tanaka M (2019) Expression of alpha-synuclein is regulated in a neuronal cell type-dependent manner. Anat Sci Int 94:11\u201322. https:\/\/doi.org\/10.1007\/s12565-018-0464-8","journal-title":"Anat Sci Int"},{"key":"1687_CR68","doi-asserted-by":"publisher","first-page":"e89327","DOI":"10.1371\/journal.pone.0089327","volume":"9","author":"K Taguchi","year":"2014","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tatebe H, Miyata S, Tokuda T et al (2014) Differential expression of alpha-synuclein in hippocampal neurons. PLoS ONE 9:e89327. https:\/\/doi.org\/10.1371\/journal.pone.0089327","journal-title":"PLoS ONE"},{"key":"1687_CR69","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/mds.20391","volume":"20","author":"EK Tan","year":"2005","unstructured":"Tan EK, Chandran VR, Fook-Chong S, Shen H, Yew K, Teoh ML et al (2005) Alpha-synuclein mRNA expression in sporadic Parkinson\u2019s disease. Mov Disord 20:620\u2013623. https:\/\/doi.org\/10.1002\/mds.20391","journal-title":"Mov Disord"},{"key":"1687_CR70","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1097\/00001756-200109170-00018","volume":"12","author":"K Tanji","year":"2001","unstructured":"Tanji K, Mori F, Nakajo S, Imaizumi T, Yoshida H, Hirabayashi T et al (2001) Expression of beta-synuclein in normal human astrocytes. NeuroReport 12:2845\u20132848. https:\/\/doi.org\/10.1097\/00001756-200109170-00018","journal-title":"NeuroReport"},{"key":"1687_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-020-00603-8","volume":"12","author":"AE Thomann","year":"2020","unstructured":"Thomann AE, Berres M, Goettel N, Steiner LA, Monsch AU (2020) Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment. Alzheimers Res Ther 12:39. https:\/\/doi.org\/10.1186\/s13195-020-00603-8","journal-title":"Alzheimers Res Ther"},{"key":"1687_CR72","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/dds238","volume":"21","author":"D Trabzuni","year":"2012","unstructured":"Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C et al (2012) MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet 21:4094\u20134103. https:\/\/doi.org\/10.1093\/hmg\/dds238","journal-title":"Hum Mol Genet"},{"key":"1687_CR73","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27:494\u2013506. https:\/\/doi.org\/10.1111\/j.1440-1789.2007.00803.x","journal-title":"Neuropathology"},{"key":"1687_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A et al (2012) RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14:22\u201329. https:\/\/doi.org\/10.1016\/j.jmoldx.2011.08.002","journal-title":"J Mol Diagn"},{"key":"1687_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","volume":"26","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhu R, Pan B, Xu H, Olufemi MF, Gathagan RJ et al (2023) Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein. Nat Neurosci 26:213\u2013225. https:\/\/doi.org\/10.1038\/s41593-022-01239-7","journal-title":"Nat Neurosci"},{"key":"1687_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD et al (2016) Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89:37\u201353. https:\/\/doi.org\/10.1016\/j.neuron.2015.11.013","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01687-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:06:41Z","timestamp":1700741201000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01687-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01687-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University Health Network (UHN) Research Ethics Board (Nr. 20-5258) and the University of Toronto (Nr. 39459) and was performed per ethical standards established in the 1964 Declaration of Helsinki, updated in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GGK holds shared patent for the 5G4 antibody. All other authors declare that they have no competing interests regarding this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}